Obese and metabolic disorders

Clinical trials for Obese and metabolic disorders explained in plain language.

Never miss a new study

Get alerted when new Obese and metabolic disorders trials appear

Sign up with your email to follow new studies for Obese and metabolic disorders, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

A phase 1, Single-Center, randomized, Double-Blind, Placebo-Controlled study to evaluate the safety, tolerability, and pharmacokinetics of HRS-1597 tablets following Single-Dose administration in healthy participants and Multiple-Dose administration in obese participants, and the effect of food on the pharmacokinetics of HRS-1597 tablets

Not yet recruiting

This is a Phase 1, single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of HRS-1597 tablets following single-dose administration in healthy participants and multiple-dose administration in obese participants,…

Matched conditions: OBESE AND METABOLIC DISORDERS

Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd.

Last updated Sep 09, 2026 19:00 UTC